FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4364362103> ?p ?o ?g. }

• W4364362103 abstract "<p>Supplementary TablesSupplementary Table 1: Patient and tumor sample informationSupplementary Table 2: Tumor mutation burdenSupplementary Table 3: Unfiltered whole exome sequencing mutation analysisSupplementary Table 4: Filtered whole exome sequencing mutation analysisSupplementary Table 5: Immunohistochemistry scores of tumorsSupplementary Table 6: FACS panel for PBMC analysisSupplementary Table 7: Geometric mean fluorescence intensity (GMFI) from PBMC FACSSupplementary Table 8: Representativeness of Study Participants</p>" @default.
• W4364362103 created "2023-04-12" @default.
• W4364362103 creator A5001296274 @default.
• W4364362103 creator A5001308517 @default.
• W4364362103 creator A5005720140 @default.
• W4364362103 creator A5008135649 @default.
• W4364362103 creator A5014780308 @default.
• W4364362103 creator A5015458809 @default.
• W4364362103 creator A5018798845 @default.
• W4364362103 creator A5020254333 @default.
• W4364362103 creator A5024888036 @default.
• W4364362103 creator A5026537645 @default.
• W4364362103 creator A5026553060 @default.
• W4364362103 creator A5031088617 @default.
• W4364362103 creator A5032422193 @default.
• W4364362103 creator A5033372450 @default.
• W4364362103 creator A5033555611 @default.
• W4364362103 creator A5036296799 @default.
• W4364362103 creator A5048218662 @default.
• W4364362103 creator A5049901305 @default.
• W4364362103 creator A5051789976 @default.
• W4364362103 creator A5058612163 @default.
• W4364362103 creator A5059640571 @default.
• W4364362103 creator A5062941900 @default.
• W4364362103 creator A5079166812 @default.
• W4364362103 creator A5079510865 @default.
• W4364362103 creator A5079853830 @default.
• W4364362103 creator A5083779488 @default.
• W4364362103 creator A5088347458 @default.
• W4364362103 date "2023-04-11" @default.
• W4364362103 modified "2023-10-18" @default.
• W4364362103 title "Supplementary Tables 1 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy" @default.
• W4364362103 doi "https://doi.org/10.1158/1078-0432.22587036" @default.
• W4364362103 hasPublicationYear "2023" @default.
• W4364362103 type Work @default.
• W4364362103 citedByCount "0" @default.
• W4364362103 crossrefType "posted-content" @default.
• W4364362103 hasAuthorship W4364362103A5001296274 @default.
• W4364362103 hasAuthorship W4364362103A5001308517 @default.
• W4364362103 hasAuthorship W4364362103A5005720140 @default.
• W4364362103 hasAuthorship W4364362103A5008135649 @default.
• W4364362103 hasAuthorship W4364362103A5014780308 @default.
• W4364362103 hasAuthorship W4364362103A5015458809 @default.
• W4364362103 hasAuthorship W4364362103A5018798845 @default.
• W4364362103 hasAuthorship W4364362103A5020254333 @default.
• W4364362103 hasAuthorship W4364362103A5024888036 @default.
• W4364362103 hasAuthorship W4364362103A5026537645 @default.
• W4364362103 hasAuthorship W4364362103A5026553060 @default.
• W4364362103 hasAuthorship W4364362103A5031088617 @default.
• W4364362103 hasAuthorship W4364362103A5032422193 @default.
• W4364362103 hasAuthorship W4364362103A5033372450 @default.
• W4364362103 hasAuthorship W4364362103A5033555611 @default.
• W4364362103 hasAuthorship W4364362103A5036296799 @default.
• W4364362103 hasAuthorship W4364362103A5048218662 @default.
• W4364362103 hasAuthorship W4364362103A5049901305 @default.
• W4364362103 hasAuthorship W4364362103A5051789976 @default.
• W4364362103 hasAuthorship W4364362103A5058612163 @default.
• W4364362103 hasAuthorship W4364362103A5059640571 @default.
• W4364362103 hasAuthorship W4364362103A5062941900 @default.
• W4364362103 hasAuthorship W4364362103A5079166812 @default.
• W4364362103 hasAuthorship W4364362103A5079510865 @default.
• W4364362103 hasAuthorship W4364362103A5079853830 @default.
• W4364362103 hasAuthorship W4364362103A5083779488 @default.
• W4364362103 hasAuthorship W4364362103A5088347458 @default.
• W4364362103 hasBestOaLocation W43643621031 @default.
• W4364362103 hasConcept C104317684 @default.
• W4364362103 hasConcept C10590036 @default.
• W4364362103 hasConcept C121608353 @default.
• W4364362103 hasConcept C126322002 @default.
• W4364362103 hasConcept C137061746 @default.
• W4364362103 hasConcept C143998085 @default.
• W4364362103 hasConcept C16671776 @default.
• W4364362103 hasConcept C202751555 @default.
• W4364362103 hasConcept C2775949291 @default.
• W4364362103 hasConcept C2777701055 @default.
• W4364362103 hasConcept C2780030458 @default.
• W4364362103 hasConcept C41008148 @default.
• W4364362103 hasConcept C45235069 @default.
• W4364362103 hasConcept C501734568 @default.
• W4364362103 hasConcept C502942594 @default.
• W4364362103 hasConcept C54355233 @default.
• W4364362103 hasConcept C71924100 @default.
• W4364362103 hasConcept C77088390 @default.
• W4364362103 hasConcept C86803240 @default.
• W4364362103 hasConceptScore W4364362103C104317684 @default.
• W4364362103 hasConceptScore W4364362103C10590036 @default.
• W4364362103 hasConceptScore W4364362103C121608353 @default.
• W4364362103 hasConceptScore W4364362103C126322002 @default.
• W4364362103 hasConceptScore W4364362103C137061746 @default.
• W4364362103 hasConceptScore W4364362103C143998085 @default.
• W4364362103 hasConceptScore W4364362103C16671776 @default.
• W4364362103 hasConceptScore W4364362103C202751555 @default.
• W4364362103 hasConceptScore W4364362103C2775949291 @default.
• W4364362103 hasConceptScore W4364362103C2777701055 @default.
• W4364362103 hasConceptScore W4364362103C2780030458 @default.
• W4364362103 hasConceptScore W4364362103C41008148 @default.
• W4364362103 hasConceptScore W4364362103C45235069 @default.
• W4364362103 hasConceptScore W4364362103C501734568 @default.
• W4364362103 hasConceptScore W4364362103C502942594 @default.
• W4364362103 hasConceptScore W4364362103C54355233 @default.

• next